Molecular Partners Ag (MOLN) Income from Continuing Operations: 2020-2025
Historic Income from Continuing Operations for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$14,796.
- Molecular Partners Ag's Income from Continuing Operations rose 21.85% to -$14,796 in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.3 million, marking a year-over-year increase of 0.26%. This contributed to the annual value of -$61.4 million for FY2024, which is 10.99% up from last year.
- Latest data reveals that Molecular Partners Ag reported Income from Continuing Operations of -$14,796 as of Q3 2025, which was up 99.94% from -$24.6 million recorded in Q2 2025.
- In the past 5 years, Molecular Partners Ag's Income from Continuing Operations ranged from a high of $122.2 million in Q4 2022 and a low of -$69.8 million during Q4 2023.
- In the last 3 years, Molecular Partners Ag's Income from Continuing Operations had a median value of -$18,934 in 2024 and averaged -$17.3 million.
- In the last 5 years, Molecular Partners Ag's Income from Continuing Operations soared by 1,005.57% in 2022 and then slumped by 378,595.28% in 2023.
- Quarterly analysis of 5 years shows Molecular Partners Ag's Income from Continuing Operations stood at -$13,406 in 2021, then declined by 2.90% to $122.2 million in 2022, then slumped by 157.15% to -$69.8 million in 2023, then rose by 11.73% to -$61.6 million in 2024, then rose by 21.85% to -$14,796 in 2025.
- Its Income from Continuing Operations was -$14,796 in Q3 2025, compared to -$24.6 million in Q2 2025 and -$18,655 in Q1 2025.